Ganglioside GD2 Expression Is Associated With Unfavorable Prognosis in Early Triple-negative Breast Cancer. Higashi C, Saito K, Kozuka Y, Yuasa H, et al. Anticancer Res 2023;43:4045-4053.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Higashi C, Saito K, Kozuka Y, Yuasa H, et al. Ganglioside GD2 Expression Is Associated With Unfavorable Prognosis in Early Triple-negative Breast Cancer. Anticancer Res 2023;43:4045-4053.
PMID: 37648305